Politics
Photo Illustration by The Daily Beast/Photo Getty
FDA Keeps Brand-Name Drugs on a Fast Path to Market ― Despite Manufacturing Concerns
QUALITY CONTROL
The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors.
